SCHEMBL18748833

SCHEMBL18748833

COC(=O)Nc1ccccc1COc1ccc(C)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
HPGD P15428 3/20 0.48
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
RAB9A P51151 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
FFAR4 Q5NUL3 2/20 0.44
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18748973 0.90 SMN1; SMN2 (0.58) MAPTMRGPRX4HPGDALDH1A1MEN1
SCHEMBL18749778 0.89 HPGD (0.54) MAPTMRGPRX4HPGDALDH1A1CYP1A2
SCHEMBL18749745 0.89 HPGD (0.54) MAPTMRGPRX4HPGDMEN1KMT2A
SCHEMBL20425116 0.89 LMNA (0.58) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL18748809 0.88 KMT2A (0.50) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL18748940 0.88 MAPT (0.45) MAPTHPGDALDH1A1MEN1KMT2A
SCHEMBL8174651 0.88 KMT2A (0.51) MAPTALDH1A1MEN1KMT2ACYP1A2
SCHEMBL18515397 0.88 FFAR4 (0.48) MAPTALDH1A1MEN1KMT2ARAB9A
SCHEMBL18748986 0.88 SMN1; SMN2 (0.46) MAPTMRGPRX4HPGDALDH1A1MEN1
SCHEMBL18749277 0.87 MAPT (0.47) MAPTMRGPRX4HPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10040768-B2 Carbamate compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-08-07 US disclosed
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 US disclosed
US-20180014539-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-18 US disclosed
US-20180002294-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-04 US disclosed
US-20180002291-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-04 US disclosed
US-20170360044-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-21 US disclosed
US-20170342032-A1 CARBAMATE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-30 US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10040768-B2 Carbamate compound and use thereof C9, C5, C1S MAPT 3358/4885MRGPRX4 814/4885HPGD 4389/4885
US-20180014539-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S MAPT 3347/4885MRGPRX4 763/4885HPGD 4443/4885
US-20170360044-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S MAPT 3184/4885MRGPRX4 620/4885HPGD 4194/4885
US-20170342032-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S MAPT 3169/4885MRGPRX4 554/4885HPGD 4207/4885
US-20180002291-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S MAPT 3308/4885MRGPRX4 703/4885HPGD 4441/4885
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 MAPT 3329/4885MRGPRX4 959/4885HPGD 4800/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 MAPT 2998/4885MRGPRX4 778/4885HPGD 4398/4885
US-20180002294-A1 CARBAMATE COMPOUND AND USE THEREOF C9, C5, C1S MAPT 3358/4885MRGPRX4 814/4885HPGD 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.